Tatiana P. Morais
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Tatiana P. Morais has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Ana Maria Sebastião
Instituto de Farmacologia e Neurociências, Faculdade de Medicina Universidade de Lisboa Lisboa Portugal
3 shared publications - Vincenzo Crunelli
Neuroscience Division, School of Bioscience, Cardiff University, Museum Avenue, Cardiff CF10 3AX, UK
3 shared publications - Giulia Salamanca
Department of Veterinary Medical Sciences University of Bologna, Italy
2 shared publications - Giuseppe Di Giovanni
Neuroscience Division, School of Bioscience, Cardiff University, Museum Avenue, Cardiff CF10 3AX, UK
2 shared publications - Sandra Henriques Vaz
Instituto de Farmacologia e Neurociências, Faculdade de Medicina Universidade de Lisboa Lisboa Portugal
2 shared publications - Christoffer Bundgaard
H. Lundbeck A/S, Global Research, Copenhagen-Valby, Denmark
1 shared publication
Latest Publications
- Open Access
- 11 June 2026
- Published by Elsevier in Neuropharmacology
- Vol. 298, 111073
Thalamic 5-HT2A receptor activation reduces GABA uptake, increases tonic GABAA inhibition and induces absence seizures in Wistar rats
- 11 June 2026
- Published by Elsevier in Neuropharmacology
- Vol. 298, 111073
Open AccessThalamic 5-HT2A receptor activation reduces GABA uptake, increases tonic GABAA inhibition and induces absence seizures in Wistar rats
Developmental and cell type‐specific contributions of thalamic serotonin 2A receptors to absence seizures
Objective: Serotonin 2A receptors (5‐HT 2A Rs) play a complex role in focal and generalized seizures due to their diverse cellular and regional distribution. Although systemic activation of 5‐HT 2A Rs suppresses absence seizures (ASs) in Genetic Absence Epilepsy Rats From Strasbourg (GAERS) rats, the contribution of thalamic receptors and their cell‐type specificity remains unclear. Here, we performed a developmental immunohistochemical analysis in the nucleus reticularis thalami (NRT) and the ventrobasal thalamic nucleus (VB) of GAERS rats to assess developmental alterations in 5‐HT 2A R expression and used genetic manipulation to determine whether the antiabsence effect of systemic 5‐HT 2A R activation depends on thalamocortical (TC) neurons or astrocytes. Methods: Double‐immunofluorescence labeling of 5‐HT 2A Rs with either γ‐aminobutyric acid (GABA) or glial fibrillary acidic protein in adult GAERS rats was used to investigate the neuronal and astrocytic distribution of these receptors in the NRT and VB. In addition, [ 3 H]GABA uptake and its modulation by 5‐HT 2A R activation were assessed in thalamic slices. Electroencephalographic and video recordings in freely moving GAERS were used to evaluate the effects of VB microinjection of TCB‐2, a 5‐HT 2A R agonist, on ASs. Finally, the cellular mechanisms underlying these effects were investigated using selective shRNA‐mediated knockdown of 5‐HT 2A Rs in either TC neurons or astrocytes in the VB. Results: In the VB, at postnatal day (P) 25, 5‐HT 2A Rs were mainly expressed in TC neurons and in the majority of the few GABAergic interneurons, whereas by P90 they were exclusively localized to TC neurons. In the NRT, neuronal expression increased from ~60% to nearly 100% over development. Astrocytic 5‐HT 2A R expression increased developmentally in the NRT but remained unchanged in the VB. GABA uptake was decreased in GAERS compared to Wistar rats and was not modified by 5‐HT 2A R activation. In vivo, intra‐VB injection of TCB‐2 reduced ASs; this effect was abolished by shRNA knockdown of 5‐HT 2A Rs in TC neurons, but not in astrocytes. Significance: The developmental reorganization of thalamic 5‐HT 2A R signaling coincides with the expression of ASs, suggesting a contributory role. Our findings indicate that neuronal, but not astrocytic, thalamic 5‐HT 2A Rs drive seizure modulation, identifying a potential therapeutic target.
Developmental and cell type‐specific contributions of thalamic serotonin 2A receptors to absence seizures
Objective: Serotonin 2A receptors (5‐HT 2A Rs) play a complex role in focal and generalized seizures due to their diverse cellular and regional distribution. Although systemic activation of 5‐HT 2A Rs suppresses absence seizures (ASs) in Genetic Absence Epilepsy Rats From Strasbourg (GAERS) rats, the contribution of thalamic receptors and their cell‐type specificity remains unclear. Here, we performed a developmental immunohistochemical analysis in the nucleus reticularis thalami (NRT) and the ventrobasal thalamic nucleus (VB) of GAERS rats to assess developmental alterations in 5‐HT 2A R expression and used genetic manipulation to determine whether the antiabsence effect of systemic 5‐HT 2A R activation depends on thalamocortical (TC) neurons or astrocytes. Methods: Double‐immunofluorescence labeling of 5‐HT 2A Rs with either γ‐aminobutyric acid (GABA) or glial fibrillary acidic protein in adult GAERS rats was used to investigate the neuronal and astrocytic distribution of these receptors in the NRT and VB. In addition, [ 3 H]GABA uptake and its modulation by 5‐HT 2A R activation were assessed in thalamic slices. Electroencephalographic and video recordings in freely moving GAERS were used to evaluate the effects of VB microinjection of TCB‐2, a 5‐HT 2A R agonist, on ASs. Finally, the cellular mechanisms underlying these effects were investigated using selective shRNA‐mediated knockdown of 5‐HT 2A Rs in either TC neurons or astrocytes in the VB. Results: In the VB, at postnatal day (P) 25, 5‐HT 2A Rs were mainly expressed in TC neurons and in the majority of the few GABAergic interneurons, whereas by P90 they were exclusively localized to TC neurons. In the NRT, neuronal expression increased from ~60% to nearly 100% over development. Astrocytic 5‐HT 2A R expression increased developmentally in the NRT but remained unchanged in the VB. GABA uptake was decreased in GAERS compared to Wistar rats and was not modified by 5‐HT 2A R activation. In vivo, intra‐VB injection of TCB‐2 reduced ASs; this effect was abolished by shRNA knockdown of 5‐HT 2A Rs in TC neurons, but not in astrocytes. Significance: The developmental reorganization of thalamic 5‐HT 2A R signaling coincides with the expression of ASs, suggesting a contributory role. Our findings indicate that neuronal, but not astrocytic, thalamic 5‐HT 2A Rs drive seizure modulation, identifying a potential therapeutic target.
- Open Access
Systemic administration of ivabradine, a hyperpolarization‐activated cyclic nucleotide‐gated channel inhibitor, blocks spontaneous absence seizures
Objective: Hyperpolarization‐activated cyclic nucleotide‐gated (HCN) channels are known to be involved in the generation of absence seizures (ASs), and there is evidence that cortical and thalamic HCN channel dysfunctions may have a proabsence role. Many HCN channel blockers are available, but their role in ASs has been investigated only by localized brain injection or in in vitro model systems due to their limited brain availability. Here, we investigated the effect on ASs of orally administered ivabradine (an HCN channel blocker approved for the treatment of heart failure in humans) following injection of the P‐glycoprotein inhibitor elacridar, which is known to increase penetration into the brain of drug substrates for this efflux transporter. The action of ivabradine was also tested following in vivo microinjection into the cortical initiation network (CIN) of the somatosensory cortex and in the thalamic ventrobasal nucleus (VB) as well as on cortical and thalamocortical neurons in brain slices.Methods: We used electroencephalographic recordings in freely moving Genetic Absence Epilepsy Rats From Strasbourg (GAERSs) to assess the action of oral administration of ivabradine, with and without elacridar, on ASs. Ivabradine was also microinjected into the CIN and VB of GAERSs in vivo and applied to Wistar CIN and GAERS VB slices while recording patch‐clamped cortical Layer 5/6 and thalamocortical neurons, respectively.Results: Oral administration of ivabradine markedly and dose‐dependently reduced ASs. Ivabradine injection into CIN abolished ASs and elicited small‐amplitude 4–7‐Hz waves (without spikes), whereas in the VB it was less potent. Moreover, ivabradine applied to GAERS VB and Wistar CIN slices selectively decreased HCN channel‐dependent properties of cortical Layer 5/6 pyramidal and thalamocortical neurons, respectively.Significance: These results provide the first demonstration of the antiabsence action of a systemically administered HCN channel blocker, indicating the potential of this class of drugs as a novel therapeutic avenue for ASs.
Open AccessSystemic administration of ivabradine, a hyperpolarization‐activated cyclic nucleotide‐gated channel inhibitor, blocks spontaneous absence seizures
Objective: Hyperpolarization‐activated cyclic nucleotide‐gated (HCN) channels are known to be involved in the generation of absence seizures (ASs), and there is evidence that cortical and thalamic HCN channel dysfunctions may have a proabsence role. Many HCN channel blockers are available, but their role in ASs has been investigated only by localized brain injection or in in vitro model systems due to their limited brain availability. Here, we investigated the effect on ASs of orally administered ivabradine (an HCN channel blocker approved for the treatment of heart failure in humans) following injection of the P‐glycoprotein inhibitor elacridar, which is known to increase penetration into the brain of drug substrates for this efflux transporter. The action of ivabradine was also tested following in vivo microinjection into the cortical initiation network (CIN) of the somatosensory cortex and in the thalamic ventrobasal nucleus (VB) as well as on cortical and thalamocortical neurons in brain slices.Methods: We used electroencephalographic recordings in freely moving Genetic Absence Epilepsy Rats From Strasbourg (GAERSs) to assess the action of oral administration of ivabradine, with and without elacridar, on ASs. Ivabradine was also microinjected into the CIN and VB of GAERSs in vivo and applied to Wistar CIN and GAERS VB slices while recording patch‐clamped cortical Layer 5/6 and thalamocortical neurons, respectively.Results: Oral administration of ivabradine markedly and dose‐dependently reduced ASs. Ivabradine injection into CIN abolished ASs and elicited small‐amplitude 4–7‐Hz waves (without spikes), whereas in the VB it was less potent. Moreover, ivabradine applied to GAERS VB and Wistar CIN slices selectively decreased HCN channel‐dependent properties of cortical Layer 5/6 pyramidal and thalamocortical neurons, respectively.Significance: These results provide the first demonstration of the antiabsence action of a systemically administered HCN channel blocker, indicating the potential of this class of drugs as a novel therapeutic avenue for ASs.
- Open Access
- 17 January 2018
- Published by Frontiers Media SA in Frontiers in Molecular Neuroscience
- Vol. 10, 444
Glycine Receptor Activation Impairs ATP-Induced Calcium Transients in Cultured Cortical Astrocytes
In central nervous system, glycine receptor (GlyR) is mostly expressed in the spinal cord and brainstem, but glycinergic transmission related elements have also been identified in the brain. Astrocytes are active elements at the tripartite synapse, being responsible for the maintenance of brain homeostasis and for the fine-tuning of synaptic activity. These cells communicate, spontaneously or in response to a stimulus, by elevations in their cytosolic calcium (calcium transients, Ca2+T) that can be propagated to other cells. How these Ca2+T are negatively modulated is yet poorly understood. In this work, we evaluated GlyR expression and its role on calcium signaling modulation in rat brain astrocytes. We first proved that GlyR, predominantly subunits α2 and β, was expressed in brain astrocytes and its localization was confirmed in the cytoplasm and astrocytic processes by immunohistochemistry assays. Calcium imaging experiments in cultured astrocytes showed that glycine (500 μM), a GlyR agonist, caused a concentration-dependent reduction in ATP-induced Ca2+T, an effect abolished by the GlyR antagonist, strychnine (0.8 μM), as well as by nocodazole (1 μM), known to impair GlyR anchorage to the plasma membrane. This effect was mimicked by activation of GABAAR, another Cl--permeable channel. In summary, we demonstrated that GlyR activation in astrocytes mediates an inhibitory effect upon ATP induced Ca2+T, which most probably involves changes in membrane permeability to Cl- and requires GlyR anchorage at the plasma membrane. GlyR in astrocytes may thus be part of a mechanism to modulate astrocyte-to-neuron communication.
- 17 January 2018
- Published by Frontiers Media SA in Frontiers in Molecular Neuroscience
- Vol. 10, 444
Open AccessGlycine Receptor Activation Impairs ATP-Induced Calcium Transients in Cultured Cortical Astrocytes
In central nervous system, glycine receptor (GlyR) is mostly expressed in the spinal cord and brainstem, but glycinergic transmission related elements have also been identified in the brain. Astrocytes are active elements at the tripartite synapse, being responsible for the maintenance of brain homeostasis and for the fine-tuning of synaptic activity. These cells communicate, spontaneously or in response to a stimulus, by elevations in their cytosolic calcium (calcium transients, Ca2+T) that can be propagated to other cells. How these Ca2+T are negatively modulated is yet poorly understood. In this work, we evaluated GlyR expression and its role on calcium signaling modulation in rat brain astrocytes. We first proved that GlyR, predominantly subunits α2 and β, was expressed in brain astrocytes and its localization was confirmed in the cytoplasm and astrocytic processes by immunohistochemistry assays. Calcium imaging experiments in cultured astrocytes showed that glycine (500 μM), a GlyR agonist, caused a concentration-dependent reduction in ATP-induced Ca2+T, an effect abolished by the GlyR antagonist, strychnine (0.8 μM), as well as by nocodazole (1 μM), known to impair GlyR anchorage to the plasma membrane. This effect was mimicked by activation of GABAAR, another Cl--permeable channel. In summary, we demonstrated that GlyR activation in astrocytes mediates an inhibitory effect upon ATP induced Ca2+T, which most probably involves changes in membrane permeability to Cl- and requires GlyR anchorage at the plasma membrane. GlyR in astrocytes may thus be part of a mechanism to modulate astrocyte-to-neuron communication.